SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000947871-16-001203
Filing Date
2016-05-20
Accepted
2016-05-20 16:06:27
Documents
2
Group Members
ORBIMED CAPITAL GP V LLCORBIMED GLOBAL HEALTHCARE GP LLCSAMUEL D. ISALY

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ss1481968_sc13d.htm SC 13D 193955
2 JOINT FILING AGREEMENT ss1481968_ex9901.htm EX-99.1 25283
  Complete submission text file 0000947871-16-001203.txt   220871
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13D

Mailing Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139
Business Address 130 BROOKLINE STREET SUITE 201 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Subject) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89486 | Film No.: 161666239
SIC: 2835 In Vitro & In Vivo Diagnostic Substances